Skip to main content

As obesity drugs help people eat less, these food companies could be the biggest losers

A team of 17 Morgan Stanley analysts have broken down the impact that drugs like Wegovy and Ozempic may have on food companies.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.